» Articles » PMID: 8831447

SPECT Study of Regional Cerebral Perfusion in Neuroleptic-resistant Schizophrenic Patients Who Responded or Did Not Respond to Clozapine

Overview
Journal Am J Psychiatry
Specialty Psychiatry
Date 1996 Oct 1
PMID 8831447
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of this study was to find predictive criteria for response to clozapine.

Method: Single photon emission computed tomography studies of cerebral perfusion were done in 24 treatment-resistant schizophrenic patients while they were taking typical neuroleptics and again after they had been treated with clozapine for 6 months. Perfusion ratios of the subjects categorized as responders or nonresponders to clozapine and of the subjects in the two treatment conditions were compared. The ratios with significant between-group differences were compared to those from a normal database.

Results: Before clozapine, while taking neuroleptics, subjects who became responders to clozapine showed higher thalamic, left basal ganglia, and right prefrontal perfusion. Nonresponders to clozapine had lower prefrontal perfusion and responders had higher subcortical perfusion than subjects in the normal database. The subcortical perfusion of the responders decreased when they received clozapine.

Conclusions: The study of cerebral perfusion may contribute to the prediction of response to clozapine.

Citing Articles

Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flow.

Sun J, Zelaya F, Sendt K, McQueen G, Gillespie A, Lally J Schizophrenia (Heidelb). 2024; 10(1):122.

PMID: 39715777 PMC: 11666760. DOI: 10.1038/s41537-024-00544-3.


A systematic review of neuroimaging studies of clozapine-resistant schizophrenia.

Pang T, Chun J, Wong T, Chu S, Ma C, Honer W Schizophrenia (Heidelb). 2023; 9(1):65.

PMID: 37752161 PMC: 10522657. DOI: 10.1038/s41537-023-00392-7.


Altered Patterns of Brain Glucose Metabolism Involve More Extensive and Discrete Cortical Areas in Treatment-resistant Schizophrenia Patients Compared to Responder Patients and Controls: Results From a Head-to-Head 2-[18F]-FDG-PET Study.

Iasevoli F, DAmbrosio L, Ciccarelli M, Barone A, Gaudieri V, Cocozza S Schizophr Bull. 2022; 49(2):474-485.

PMID: 36268829 PMC: 10016407. DOI: 10.1093/schbul/sbac147.


Impact cérébral structurel et fonctionnel de la Clozapine chez les patients souffrant de schizophrénie : revue systématique des études longitudinales en neuroimagerie.

Vandevelde A, Metivier L, Dollfus S Can J Psychiatry. 2020; 66(8):683-700.

PMID: 33131322 PMC: 8329901. DOI: 10.1177/0706743720966459.


Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate.

Merritt K, Perez-Iglesias R, Sendt K, Goozee R, Jauhar S, Pepper F NPJ Schizophr. 2019; 5(1):12.

PMID: 31371817 PMC: 6672005. DOI: 10.1038/s41537-019-0080-1.